NASDAQ:TSHA | Cash Flow Statement | Taysha Gene Therapies, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$46.64M
2026-03-31-$42.41M-$40.88M$24,000.00-$3.02M$711,000.00
2025-12-31-$27.85M-$26.72M$250,000.00-$247,000.00$49.56M
2025-09-30-$32.73M
2025-06-30-$26.88M
2025-03-31-$21.53M-$22.02M$378,000.00-$371,000.00-$52,000.00
2024-12-31-$18.79M-$18.31M-$2,000.00$13,000.00-$357,000.00
2024-09-30-$25.52M
2024-06-30-$20.93M
2024-03-31-$24.06M-$19.8M$140,000.00-$140,000.00-$22,000.00
2023-12-31$47.74M-$16.12M$17,000.00-$10,000.00-$4.25M
2023-09-30-$117.09M
2023-06-30-$24.6M
2023-03-31-$17.62M-$20.19M$3.9M-$3.9M-$370,000.00
2022-12-31-$55.08M$14.71M$2.31M-$2.37M$41.23M
2022-09-30-$26.53M
2022-06-30-$34.09M
2022-03-31-$50.32M-$40.94M$8.43M-$11.43M-$107,000.00
2021-12-31-$50.39M-$40.26M$8.27M-$8.52M$9.11M
2021-09-30-$51.19M
2021-06-30-$40.93M
2021-03-31-$32.02M-$22.04M$534,000.00-$534,000.00
2020-12-31-$18.32M-$19.85M$51,000.00-$6.05M-$1.48M
2020-09-30-$15.04M
2020-06-30-$21.22M
2020-03-31-$5.43M-$1.7M$0.00$0.00$18.03M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$109M-$93.09M$738,000.00-$604,000.00$274.59M
2024-12-31-$89.3M-$81.23M$374,000.00-$363,000.00$76.68M
2023-12-31-$111.57M-$73.02M$3.87M-$7.35M$136.39M
2022-12-31-$166.01M-$88.39M$20.62M-$24.93M$52.1M
2021-12-31-$174.52M-$117.04M$15.3M-$21.55M$39.08M
2020-12-31-$60.01M-$30.73M$82,000.00-$9.08M$291.06M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.